14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 432 days ( -107.95 % )
Last Price $87.86 0 %
High/ Low $87.86 - $87.86 0%
Chg 7 Days N/A $87.86 $87.86
Chg 30 Days N/A $87.86 $87.86
Chg 12 mos N/A $87.86 $87.86
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos N/A Width: 0 %
Pred. range - 3 mos $87.86 - $87.86 0 % - 0 %
Pred. range - 12 mos N/A - N/A -100.00 % - -100.00 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Nov 30, -1 - N/A days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Immunomedics

Immunomedics Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small... IMMU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT